[Treatment of rheumatoid arthritis with immunosuppressive agents. Review of literature and personal cases. Results in 45 patients treated with cyclophosphamide for 6 years]. 1981

L Frizziero, and F Zizzi, and A Facchini, and G Zini, and A Ferruzzi, and E Mariani

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

L Frizziero, and F Zizzi, and A Facchini, and G Zini, and A Ferruzzi, and E Mariani
August 1973, Minerva medica,
L Frizziero, and F Zizzi, and A Facchini, and G Zini, and A Ferruzzi, and E Mariani
January 1978, Revue du rhumatisme et des maladies osteo-articulaires,
L Frizziero, and F Zizzi, and A Facchini, and G Zini, and A Ferruzzi, and E Mariani
September 1971, The Journal of the Medical Society of New Jersey,
L Frizziero, and F Zizzi, and A Facchini, and G Zini, and A Ferruzzi, and E Mariani
December 1971, Revue du rhumatisme et des maladies osteo-articulaires,
L Frizziero, and F Zizzi, and A Facchini, and G Zini, and A Ferruzzi, and E Mariani
January 1969, Studii si cercetari de medicina interna,
L Frizziero, and F Zizzi, and A Facchini, and G Zini, and A Ferruzzi, and E Mariani
June 1975, Revue du rhumatisme et des maladies osteo-articulaires,
L Frizziero, and F Zizzi, and A Facchini, and G Zini, and A Ferruzzi, and E Mariani
January 1974, Arthritis and rheumatism,
L Frizziero, and F Zizzi, and A Facchini, and G Zini, and A Ferruzzi, and E Mariani
January 1972, Reumatologia,
L Frizziero, and F Zizzi, and A Facchini, and G Zini, and A Ferruzzi, and E Mariani
January 1971, Polski tygodnik lekarski (Warsaw, Poland : 1960),
L Frizziero, and F Zizzi, and A Facchini, and G Zini, and A Ferruzzi, and E Mariani
January 1970, Reumatismo,
Copied contents to your clipboard!